摘要
目的探析肝硬化自发细菌性腹膜炎患者应用左氧氟沙星、头孢噻肟钠联合治疗的临床效果。方法将64例肝硬化自发细菌性腹膜炎患者以随机分为2组,对照组给予左氧氟沙星治疗,研究组在此基础上联合头孢噻肟钠治疗。结果经过2周的治疗后,研究组在相关临床指标(MN计数、腹围、内毒素血症及24 h尿量)和治疗有效率上与对照组相比,差异均具有统计学意义(P<0.05)。结论肝硬化自发细菌性腹膜炎患者应用左氧氟沙星和头孢噻肟钠,改善临床指标的同时还能提高治疗有效率。
Objective To discussion and analysis the effect of combined therapy of levofloxacin and cefotaxime sodium in the treatment of liver cirrhosis with spontaneous bacterial peritonitis.Methods64 cases of spontaneous bacterial peritonitis in patients with cirrhosis were randomly divided into 2 groups. The control group was treated with levofloxacin.ResultsAfter 2 weeks of treatment,the study group in clinical indicators（MN count,abdominal circumference,endotoxin sepsis and 24 h urine）and treatment effective rate and the control group compared to have statisticaly significant difference（P〈0.05）. Conclusion Application of levofloxacin and cefotaxime sodium in the patients with spontaneous bacterial peritonitis with liver cirrhosis,can significantly improve the clinical indicators and improve the efficiency of treatment.
出处
《中国卫生标准管理》
2016年第15期95-96,共2页
China Health Standard Management
关键词
肝硬化
自发细菌性腹膜炎
左氧氟沙星
头孢噻肟钠
Liver cirrhosis
Spontaneous bacterial peritonitis
Levofloxacin
Cefotaxime sodium
